Puma Bio Stock: Still Worthy After Earnings Surprise (NASDAQ:PBYI) | Seeking Alpha
With 53% institutional ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) is a favorite amongst the big guns | Nasdaq
Puma Biotechnology Inc (PBYI) Stock 10 Year History
Puma Biotechnology Earnings: PBYI Stock Skyrockets on Q4 Results | InvestorPlace
PBYI Institutional Ownership and Shareholders - Puma Biotechnology Inc (NASDAQ) Stock
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma Biotechnology Inc (PBYI) Pops 60% on FDA Review | InvestorPlace
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat
Puma Biotechnology - Crunchbase Company Profile & Funding
Puma Biotechnology Surging
Puma Biotechnology Inc (PBYI) Stock Price & Performance 2022
Is Puma Biotechnology Inc (PBYI) a Bad Choice in Biotechnology Wednesday?
Here's Why The Puma Biotechnology Inc (NYSE:PBYI) Pullback Might Be A Buy-In Opportunity - Market Exclusive
Have Puma Biotechnology, Inc. (NASDAQ:PBYI) Insiders Been Selling Their Stock? - Simply Wall St News
Why Puma Biotechnology (PBYI) Stock Is Surging Today - TheStreet
Stocks to Watch: Dropbox, Nike, Tronc, Qualcomm, Puma Biotechnology, Invitation Homes, Universal Display - WSJ
PUMA BIOTECHNOLOGY, INC. - FORM S-1/A - EX-4.1 - FORM OF COMMON STOCK CERTIFICATE - February 1, 2012
Puma Biotechnology (PBYI) Stock Climbs On Orphan Drug Designation | Alpha Stock News
PBYI | Puma Biotechnology Inc. Stock Overview (U.S.: Nasdaq) | Barron's
Puma Biotechnology Stock Quote. PBYI - Stock Price, News, Charts, Message Board, Trades
Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha
